FILINGS
BRTX 0001505497 | |||
---|---|---|---|
Filing Date | Form Type | Description | Document |
2024-12-05 | SCHEDULE 13G/A | View Document | |
2024-11-14 | SCHEDULE 13G/A | View Document | |
2024-11-13 | 8-K | THIRD QUARTER RESULTS AND ORS PRESENTATION | View Document |
2024-11-13 | S-8 | View Document | |
2024-11-12 | 10-Q | View Document | |
2024-11-07 | 8-K | ADDITIONAL PRELIMINARY PHASE 2 DATA AND REVIEW OF THIRD QUARTER CONFERENCE CALL | View Document |
2024-11-06 | 8-K | RODMAN & RENSHAW AT THE MARKET OFFERING AGREEMENT | View Document |
2024-11-06 | 424B5 | PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED FEBRUARY 14, 2023 | View Document |
2024-11-06 | 10-K/A | View Document | |
2024-11-05 | 4 | View Document | |
2024-09-23 | 8-K | SHAREHOLDER VOTE | View Document |
2024-08-13 | 10-Q | View Document | |
2024-08-13 | 8-K | SECOND QUARTER RESULTS | View Document |
2024-08-08 | DEF 14A | ANNUAL MEETING PROXY STATEMENT | View Document |
2024-08-06 | 8-K | PRESS RELEASE RE SECOND QUARTER RESULTS AND CONFERENCE CALL | View Document |
2024-06-21 | SCHEDULE 13G | View Document | |
2024-06-11 | 10-Q | View Document | |
2024-06-11 | 10-K/A | View Document | |
2024-05-24 | 8-K | RE DELISTING | View Document |
2024-05-24 | 8-K | RE: RESTATEMENT | View Document |
2024-05-16 | NT 10-Q | MARCH 31, 2024 | View Document |
2024-04-19 | 424B3 | 2,513,686 SHARES OF COMMON STOCK | View Document |
2024-04-18 | EFFECT | View Document | |
2024-04-17 | CORRESP | View Document | |
2024-04-12 | S-1/A | AMENDMENT NO. 1 | View Document |
2024-04-11 | UPLOAD | View Document | |
2024-04-10 | 4 | View Document | |
2024-04-03 | S-1 | S-1 | View Document |
2024-04-01 | 10-K | View Document | |
2024-03-20 | 4 | View Document | |
2024-03-20 | 4 | View Document | |
2024-03-12 | 8-K | RE PRESENTATION MATERIALS | View Document |
2024-03-06 | SC 13D/A | SCHEDULE 13D AMENDMENT 9 | View Document |
2024-02-15 | SC 13D/A | SCHEDULE 13D/AMENDMENT 2 | View Document |
2024-02-15 | SC 13D/A | SCHEDULE 13D AMENDMENT 2 | View Document |
2024-02-15 | 4 | View Document | |
2024-02-15 | 4 | View Document | |
2024-02-15 | 4 | View Document | |
2024-02-15 | 4 | View Document | |
2024-02-15 | 4 | View Document | |
2024-02-15 | 4 | View Document | |
2024-02-15 | 4 | View Document | |
2024-02-14 | SC 13G/A | View Document | |
2024-02-12 | 4 | View Document | |
2024-02-09 | 4 | View Document | |
2024-02-08 | 8-K | FORM 8-K DATED FEBRUARY 6, 2024 | View Document |
2024-02-05 | 8-K | RE AUTOLOGOUS STEM CELL THERAPY POSTER | View Document |
2024-02-01 | 8-K | PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL | View Document |
2023-12-05 | 4 | View Document | |
2023-12-01 | 4 | View Document | |
2023-11-15 | S-8 | REGISTRATION OF ADDITIONAL 1,350,000 UNDER 2021 STOCK INCENTIVE PLAN | View Document |
2023-11-13 | 10-Q | View Document | |
2023-09-18 | 4 | View Document | |
2023-09-18 | 4 | View Document | |
2023-09-15 | 8-K | SHAREHOLDER VOTE | View Document |
2023-09-14 | 4 | View Document | |
2023-09-13 | 4 | View Document | |
2023-09-06 | 4 | View Document | |
2023-08-31 | 4 | View Document | |
2023-08-23 | 424B5 | SUPPLEMENT NO. 3 TO PROSPECTUS SUPPLEMENT DATED APRIL 14, 2023 | View Document |
2023-08-11 | 10-Q | View Document | |
2023-08-04 | DEF 14A | 2023 ANNUAL MEETING PROXY STATEMENT | View Document |
2023-07-28 | 4 | View Document | |
2023-07-25 | 4 | View Document | |
2023-07-13 | 8-K | FORM 8-K DATED JULY 11, 2023 | View Document |
2023-07-13 | 424B5 | View Document | |
2023-07-11 | 424B5 | SUPPLEMENT NO. 2 | View Document |
2023-05-15 | 424B5 | SUPPLEMENT NO. 1 TO PROSPECTUS SUPPLEMENT DATED APRIL 14, 2023 | View Document |
2023-05-12 | 10-Q | View Document | |
2023-04-14 | 8-K | View Document | |
2023-04-14 | 424B2 | View Document | |
2023-04-06 | 8-K | RE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT | View Document |
2023-04-04 | 4 | View Document | |
2023-03-28 | S-8 | FORM S-8 DATED MARCH 28, 2023 | View Document |
2023-03-27 | 10-K | View Document | |
2023-03-22 | 4 | View Document | |
2023-03-22 | 4 | View Document | |
2023-03-03 | 4 | FORM 4 | View Document |
2023-02-28 | 4 | FORM 4 | View Document |
2023-02-27 | 4 | FORM 4 | View Document |
2023-02-17 | 4 | FORM 4 | View Document |
2023-02-17 | 4 | FORM 4 | View Document |
2023-02-17 | 4 | FORM 4 | View Document |
2023-02-17 | 4 | FORM 4 | View Document |
2023-02-17 | 4 | FORM 4 | View Document |
2023-02-17 | 4 | FORM 4 | View Document |
2023-02-17 | 4 | FORM 4 | View Document |
2023-02-17 | SC 13D/A | AMENDMENT 1 | View Document |
2023-02-17 | SC 13D/A | AMENDMENT 1 | View Document |
2023-02-14 | EFFECT | View Document | |
2023-02-14 | SC 13G/A | View Document | |
2023-02-13 | CORRESP | View Document | |
2023-02-13 | S-3/A | AMENDMENT 1 | View Document |
2023-02-10 | UPLOAD | View Document | |
2023-02-07 | S-3 | COMMON STOCK, PREFERRED STOCK, WARRANTS, DEBT SECURITIES AND UNITS | View Document |
2023-02-07 | SC 13G/A | BRTX 13GA | View Document |
2023-02-02 | 4 | FORM 4 | View Document |
2023-01-30 | 4 | FORM 4 | View Document |
2023-01-24 | 4 | FORM 4 | View Document |
2023-01-20 | 4 | FORM 4 | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.